EP2536406A4 - Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses - Google Patents

Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses

Info

Publication number
EP2536406A4
EP2536406A4 EP11740333.7A EP11740333A EP2536406A4 EP 2536406 A4 EP2536406 A4 EP 2536406A4 EP 11740333 A EP11740333 A EP 11740333A EP 2536406 A4 EP2536406 A4 EP 2536406A4
Authority
EP
European Patent Office
Prior art keywords
antiseptics
thiols
bismuth
including treatment
bacterial biofilms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP11740333.7A
Other languages
German (de)
French (fr)
Other versions
EP2536406A2 (en
Inventor
Brett Hugh James Baker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbion Corp
Original Assignee
Microbion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2010/023108 external-priority patent/WO2010091124A2/en
Application filed by Microbion Corp filed Critical Microbion Corp
Publication of EP2536406A2 publication Critical patent/EP2536406A2/en
Publication of EP2536406A4 publication Critical patent/EP2536406A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N55/00—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
    • A01N55/02—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur containing metal atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
EP11740333.7A 2010-02-03 2011-02-03 Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses Pending EP2536406A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/US2010/023108 WO2010091124A2 (en) 2009-02-03 2010-02-03 Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
US37318810P 2010-08-12 2010-08-12
PCT/US2011/023549 WO2011097347A2 (en) 2010-02-03 2011-02-03 Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses

Publications (2)

Publication Number Publication Date
EP2536406A2 EP2536406A2 (en) 2012-12-26
EP2536406A4 true EP2536406A4 (en) 2014-04-09

Family

ID=51355699

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11740333.7A Pending EP2536406A4 (en) 2010-02-03 2011-02-03 Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses

Country Status (7)

Country Link
EP (1) EP2536406A4 (en)
JP (1) JP2013518895A (en)
CN (2) CN107308186A (en)
AU (1) AU2011212941B2 (en)
CA (1) CA2788669C (en)
MX (1) MX346409B (en)
WO (1) WO2011097347A2 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005072710A2 (en) 2004-01-28 2005-08-11 Johns Hopkins University Drugs and gene carrier particles that rapidly move through mucous barriers
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
JP6360040B2 (en) 2012-05-03 2018-07-18 カラ ファーマシューティカルズ インコーポレイテッド Mucus-permeable coated particles, compositions, pharmaceutical compositions, pharmaceutical formulations, and methods for forming them
EP4008355A1 (en) 2012-05-03 2022-06-08 Kala Pharmaceuticals, Inc. Pharmaceutical nanoparticles showing improved mucosal transport
ES2688381T3 (en) * 2012-09-28 2018-11-02 Stelo Technologies Methods for making silver nanoparticles and their applications
CN103667119B (en) * 2013-11-26 2015-07-29 浙江大学 For the bacterial strain of sulfur alcohol of degrading and cultural method thereof and application
US11039620B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US9622483B2 (en) 2014-02-19 2017-04-18 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039621B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
ES2941460T3 (en) * 2014-03-07 2023-05-23 Mark Tuffley Composition and method for improving wound healing
CN105572126B (en) * 2015-04-07 2018-10-23 湖南华纳大药厂股份有限公司 A kind of colloidal bismmth pectin pharmaceutical composition
MX2017012727A (en) 2015-04-08 2018-05-28 Biomendics Llc Formulation and process for modulating wound healing.
WO2017145142A1 (en) 2016-02-25 2017-08-31 Nobio Ltd. Micro and nanoparticulate compositions comprising anti-microbially active groups
ES2912268T3 (en) * 2016-12-05 2022-05-25 Technophage Investig E Desenvolvimento Em Biotecnologia Sa Bacteriophage compositions comprising respiratory antibacterial phages and methods of using same
AU2017381394A1 (en) * 2016-12-22 2019-07-25 The University Of Sydney Biofilm disrupting composition
JP7337778B2 (en) 2017-08-30 2023-09-04 ノビオ リミテッド Compositions and medical devices containing antimicrobial particles
ES2892077T3 (en) * 2017-11-16 2022-02-02 Dsm Ip Assets Bv Use of phytantriol as an antimicrobial agent in the preservation of a composition
CN110387416B (en) * 2018-04-16 2022-06-17 华东理工大学 Nano-gold dual-probe system with controllable polymerization regulation function and application thereof
WO2020028561A1 (en) * 2018-07-31 2020-02-06 Microbion Corporation Bismuth-thiol compositions and methods for treating wounds
WO2020028558A1 (en) 2018-07-31 2020-02-06 Microbion Corporation Bismuth-thiol compositions and methods of use
CN110870874A (en) * 2018-08-13 2020-03-10 中山大学 Medicine with antibacterial effect and application thereof
KR102054341B1 (en) * 2019-06-20 2019-12-10 한국지질자원연구원 A pharmaceutical composition for oral administration for eradicating helicobacter pylori which is resistant to antibiotics comprising a complex of non-absorbable antibiotic and clay mineral
EP3917320A4 (en) * 2019-01-31 2022-11-09 Pulsethera Corporation Bacterialcidal methods and compositions
EP3941461A4 (en) * 2019-03-18 2022-12-14 Cedars-Sinai Medical Center Compositions and methods to treat gastrointestinal diseases and disorders
CN112425608B (en) * 2019-08-23 2023-07-21 香港科技大学 Elastase inhibitor and antibacterial agent with anti-biofilm activity
CN111034711B (en) * 2019-12-19 2022-04-05 海南一龄医疗产业发展有限公司 Composition and method for efficiently removing microbial contamination in cell culture process
CN111175103B (en) * 2020-01-16 2023-07-04 江西业力医疗器械有限公司 Leucorrhea sample pretreatment liquid for fluorescent detection of mycotic vaginitis and preparation method thereof
WO2021195236A1 (en) * 2020-03-24 2021-09-30 Microbion Corporation Bismuth thiol compounds and compositions and methods of treating microbial co-infections
CN113712842B (en) * 2020-05-25 2023-06-13 基元美业生物科技(上海)有限公司 Composition and application thereof in preparation of cosmetics and medical devices
CN112618716B (en) * 2021-01-11 2022-04-08 福州大学 Photodynamic combined lysozyme antibacterial method
CN113930462A (en) * 2021-10-19 2022-01-14 江南大学 Method for synthesizing hexanoic acid by using homoserine lactone signal molecule to promote carbon chain elongation microorganisms
CN114984746B (en) * 2022-08-05 2022-11-01 山东建筑大学 System method and device for treating VOCs waste gas in disinfectant and aquaculture wastewater pool
CN115532295B (en) * 2022-09-27 2023-07-25 苏州大学 Application of nanomaterial containing Zn-N-C active center in removal of bacterial biofilm

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020197282A1 (en) * 1999-02-23 2002-12-26 Mohseni Saeed H. Sonic method of enhancing chemical reactions to provide uniform, non-agglomerated particles
WO2010091124A2 (en) * 2009-02-03 2010-08-12 Microbion Corporation Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6086921A (en) * 1995-04-25 2000-07-11 Wintrop-University Hospital Metal/thiol biocides
US5999828A (en) * 1997-03-19 1999-12-07 Qualcomm Incorporated Multi-user wireless telephone having dual echo cancellers
AU2656799A (en) * 1998-02-04 1999-08-23 Winthrop-University Hospital Metal-thiols as imminomodulating agents
US7381751B2 (en) * 2003-08-26 2008-06-03 Shantha Sarangapani Antimicrobial composition for medical articles
US8343536B2 (en) * 2007-01-25 2013-01-01 Cook Biotech Incorporated Biofilm-inhibiting medical products

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020197282A1 (en) * 1999-02-23 2002-12-26 Mohseni Saeed H. Sonic method of enhancing chemical reactions to provide uniform, non-agglomerated particles
WO2010091124A2 (en) * 2009-02-03 2010-08-12 Microbion Corporation Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications

Also Published As

Publication number Publication date
AU2011212941A1 (en) 2012-09-27
CA2788669C (en) 2021-05-25
JP2013518895A (en) 2013-05-23
MX346409B (en) 2017-03-17
WO2011097347A2 (en) 2011-08-11
EP2536406A2 (en) 2012-12-26
CN107308186A (en) 2017-11-03
CA2788669A1 (en) 2011-08-11
MX2012009054A (en) 2012-12-17
WO2011097347A3 (en) 2011-12-22
CN103079557A (en) 2013-05-01
AU2011212941B2 (en) 2016-03-03

Similar Documents

Publication Publication Date Title
EP2536406A4 (en) Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
EP2629736A4 (en) Tissue treatment
ZA201208413B (en) Skin treatment composition
ZA201005798B (en) Treatment of microbial infections
EP2654745A4 (en) Composition for the treatment of skin conditions
GB201217097D0 (en) Treatment of bacterial infection
HK1183454A1 (en) Tamarind seed polysaccharide for use in the treatment of microbial infections
IL223289A0 (en) Treatment of type 2 diabetes
AU2011348474A1 (en) Antimicrobial composition having skin care properties
HK1180182A1 (en) Platelet-derived growth factor compositions and methods for the treatment of tendinopathies
IL225755B (en) 6-amidoderivatives of 4,5a-epoxymorphinans for treatment of pain
ZA201208568B (en) Skin treatment composition
WO2011156820A9 (en) Compositions, methods and uses for treatment of type 1 diabetes
EP2650292A4 (en) Thiazolamine derivative and use thereof as anti-picornaviral infection medicament
ZA201204249B (en) Treatment of microbial infections
EP2529728A4 (en) Pharmaceutical compositions for the treatment of bacterial infections
EP2665738A4 (en) Compounds for use in the treatment of bacterial infection
AU2010901811A0 (en) Avian-Based Treatment for Microbial Infection
AU2010904571A0 (en) Skin Treatment Formulation
GB0807781D0 (en) Treatment of bacterial infection
GB0801768D0 (en) Treatment of microbial infections
AU2009904943A0 (en) Skin Treatment Formulation
AU2012902449A0 (en) Novel animal infection treatment and prophylaxis
AU2010900846A0 (en) Treatment or prevention of infection
AU2009900969A0 (en) Treatment of infection

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120817

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1180215

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20140311

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/48 20060101AFI20140305BHEP

Ipc: C07H 21/04 20060101ALI20140305BHEP

Ipc: C12N 1/21 20060101ALI20140305BHEP

Ipc: C12N 9/64 20060101ALI20140305BHEP

Ipc: C07K 14/61 20060101ALI20140305BHEP

Ipc: C12N 5/10 20060101ALI20140305BHEP

Ipc: A61P 3/08 20060101ALI20140305BHEP

Ipc: C12N 15/63 20060101ALI20140305BHEP

Ipc: C12N 15/62 20060101ALI20140305BHEP

Ipc: A61P 3/10 20060101ALI20140305BHEP

Ipc: C07K 14/46 20060101ALI20140305BHEP

Ipc: A61P 3/04 20060101ALI20140305BHEP

Ipc: A61K 9/14 20060101ALI20140305BHEP

Ipc: A61K 38/27 20060101ALI20140305BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20170524

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS